Abstract
The expression of cyclin-dependent kinase 5 (Cdk5) and its regulatory subunits, p35 and p39, was investigated in rat brain from embryonic day 12 (E12) to postnatal 18 months (18M). The Cdk5 protein levels increased from E12 to postnatal day 7 (P7) and remained at this level until 18M. The Cdk5 kinase activity and the levels of both p35 mRNA and protein were low at E12, became prominent at E18-P14 but then decreased in the adult and aged rat brains of 3M to 18M. In comparison, the expression pattern of p39 appeared to have an inverse relationship to that of Cdk5 and p35. In regional distribution studies, p35 protein levels and Cdk5 kinase activity were significantly higher in the cerebral cortex and hippocampus, but lower in the cerebellum and striatum. These results suggested that Cdk5, p35 and p39 might have region-specific and developmental stage-specific functions in rat brain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Doree, M., and Galas, S. 1994. The cyclin-dependent protein kinases and the control of cell division. FASEB J. 8:1114–1121.
Lew, J., and Wang, J. H. 1995. Neuronal cdc2-like kinase. Trends Biochem. Sci. 20:33–37.
Tsai, L. H., Takahashi, T., Caviness, V. S. Jr., and Harlow, E. 1993. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029–1040.
Lew, J., Beaudette, K., Litwin, C. M., and Wang, J. H. 1992. Purification and characterization of a novel proline-directed protein kinase from bovine brain. J. Biol. Chem. 267:13383–13390.
Lew, J., Qi, Z., Huang, Q. Q., Paudel, H., Matsuura, I., Matsushita, M., Zhu, X., and Wang, J. H. 1995. Structure, function, and regulation of neuronal Cdc2-like protein kinase. Neurobiol. Aging. 16:263–268.
Ishiguro, K., Takamatsu, M., Tomizawa, K., Omori, A., Takahashi, M., Arioka, M., Uchida, T., and Imahori, K. 1992. Tau protein kinase I convert normal tau protein into A68-like component of paired helical filaments. J. Biol. Chem. 267:10897–10901.
Ishiguro, K., Kobayashi, S., Omori, A., Takamatsu, M., Yonekura, S., Anzai, K., Imahori, K., and Uchida, T. 1994. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of Cdk5 in bovine brain. FEBS Lett. 342:203–208.
Tsai, L. H., Delalle, I., Caviness, V. S. Jr., Chae, T., and Harlow, E. 1994. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419–423.
Tang, D., Yeung, J., Lee, K. Y., Matsushita, M., Matsui, H., Tomizawa, K., Hatase, O., and Wang, J. H. 1995. An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J. Biol. Chem. 270:26897–26903.
Pant, A. C., Veeranna., Pant. H. C., and Amin, N. 1997. Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5). Brain Res. 765:259–266.
Singh, T. J., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. 1995. Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases. FEBS Letters. 358:4–8.
Veeranna. Shetty, K. T., Link, W. T., Jaffe, H., Wang, J., and Pant, H. C. 1995. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64:2681–2690.
Sun, D., Leung, C. L., and Liem, R. K. H. 1996. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. J. Biol. Chem. 271:14245–14251.
Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F., and Tsai, L. H. 1996. The Cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10:816–825.
Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G., Veeranna. Pant, H. C., Brady, R. O., Martin, L. J., and Kulkarni, A. B. 1996. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA. 93:11173–11178.
Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., and Tsai, L. H. 1997. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18:29–42.
Imahori, K., and Uchida, T. 1997. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. 121:179–188.
Imahori, K., Hoshi, M., Ishiguro, K., Sato, K., Takahashi, M., Shiurba, R., Yamaguchi, H., Takashima, A., and Uchida, T. 1998. Possible role of tau protein kinases in pathogenesis of Alzheimer's disease. Neurobiol. Aging. 19:S93–98.
Patrick, G. N., Zukerberg, L., Nikolic, M., Monte, S. D. L., Dikkes, P., and Tsai, L. H. 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 402: 615–622.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
Gao, C. Y., Zakeri, Z., Zhu, Y., He, H., and Zelenka, P. S. 1997. Expression of Cdk5, p35, and Cdk5 kinase activity in the developing rat lens. Dev. Genetics. 20:267–275.
Zheng, M., Leung, C. L., and Liem, R. K. 1998. Region-specific expression of cyclin-dependent kinase 5 (Cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J. Neurobiol. 35:141–159.
Bayer, S. A., Altman, J., and Zhang, X. 1993. Timetables of neurogenesis in the human brain based on experimentally dertermined patterns in the rat. Neurotoxicology 14:83–144.
Qi, Z., Tang, D., Zhu, X., Fujita, D. J., and Wang, J.H. 1998. Association of neurofilament proteins with neuronal Cdk5 activator. J. Biol. Chem. 273:2329–2335.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wu, DC., Yu, YP., Lee, N.T.K. et al. The Expression of Cdk5, p35, p39, and Cdk5 Kinase Activity in Developing, Adult, and Aged Rat Brains. Neurochem Res 25, 923–929 (2000). https://doi.org/10.1023/A:1007544106645
Issue Date:
DOI: https://doi.org/10.1023/A:1007544106645